Контакты/Проезд  Доставка и Оплата Помощь/Возврат
История
  +7(495) 980-12-10
  пн-пт: 10-18 сб,вс: 11-18
  shop@logobook.ru
   
    Поиск книг                    Поиск по списку ISBN Расширенный поиск    
Найти
  Зарубежные издательства Российские издательства  
Авторы | Каталог книг | Издательства | Новинки | Учебная литература | Акции | Хиты | |
 

Biosimilars, Jean-Louis Prugnaud; Jean-Hugues Trouvin


Варианты приобретения
Цена: 16769.00р.
Кол-во:
Наличие: Поставка под заказ.  Есть в наличии на складе поставщика.
Склад Америка: Есть  
При оформлении заказа до: 2025-07-28
Ориентировочная дата поставки: Август-начало Сентября
При условии наличия книги у поставщика.

Добавить в корзину
в Мои желания

Автор: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Название:  Biosimilars
ISBN: 9782817805146
Издательство: Springer
Классификация:





ISBN-10: 2817805143
Обложка/Формат: Paperback
Страницы: 90
Вес: 0.16 кг.
Дата издания: 14.12.2014
Язык: English
Издание: 2012 ed.
Иллюстрации: 5 tables, black and white; xviii, 90 p.
Размер: 234 x 156 x 6
Читательская аудитория: Professional & vocational
Основная тема: Medicine & Public Health
Подзаголовок: A New Generation of Biologics
Ссылка на Издательство: Link
Рейтинг:
Поставляется из: Германии
Описание: Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.
Дополнительное описание: Preface: Biosimilars – a philosophy?.- Foreword.- 1. Biosimilars characteristics.- Introduction : from generics to biosimilars.- Definitions.- Complexity of biologics and examples.- Conclusion.- 2. From the biosimilar concept to the Marketing Approval. –I



Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development

Автор: Liu
Название: Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development
ISBN: 1118662318 ISBN-13(EAN): 9781118662311
Издательство: Wiley
Рейтинг:
Цена: 25653.00 р.
Наличие на складе: Поставка под заказ.

Описание: Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing.

Biosimilarity The Fda Perspective

Автор: Niazi
Название: Biosimilarity The Fda Perspective
ISBN: 1498750397 ISBN-13(EAN): 9781498750394
Издательство: Taylor&Francis
Рейтинг:
Цена: 28327.00 р.
Наличие на складе: Есть у поставщика Поставка под заказ.

Описание: The focus of this book is on how the US FDA will approve biosimilar drugs. The European scene is well developed with specific guidelines that are already in place. However, these guidelines do not apply to the thinking of the FDA in approving these products.

Biosimilar Drug Product Development

Автор: Laszlo Endrenyi and Dr. Paul Declerck
Название: Biosimilar Drug Product Development
ISBN: 1498718795 ISBN-13(EAN): 9781498718790
Издательство: Taylor&Francis
Рейтинг:
Цена: 27562.00 р.
Наличие на складе: Есть у поставщика Поставка под заказ.

Описание:

When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.


ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru
   В Контакте     В Контакте Мед  Мобильная версия